[go: up one dir, main page]

Hustey, 2000 - Google Patents

Dementia in the elderly: avoiding the pitfalls

Hustey, 2000

View HTML
Document ID
12488286633861751266
Author
Hustey F
Publication year
Publication venue
Dementia

External Links

Snippet

Emergency department (ED) encounters involving older patients with cognitive impairment are common. The incidence of dementia increases dramatically in the very elderly, the fastest growing subset of our geriatric population. Dementia is also prevalent in nursing …
Continue reading at www.clinician.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10—Services
    • G06Q50/22—Health care, e.g. hospitals; Social work
    • G06Q50/24—Patient record management
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
    • G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/345—Medical expert systems, neural networks or other automated diagnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
    • G06F19/324—Management of patient independent data, e.g. medical references in digital format
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires

Similar Documents

Publication Publication Date Title
Duong et al. Dementia: What pharmacists need to know
Davis et al. Brief screening tests versus clinical staging in senile dementia of the Alzheimer type
Wingo et al. Neurocognitive impairment in bipolar disorder patients: functional implications
Lee et al. Psychosis in Parkinson's disease without dementia: common and comorbid with other non‐motor symptoms
Sakurai et al. Japan‐multimodal intervention trial for the prevention of dementia: a randomized controlled trial
Budson et al. Memory loss E-book: A practical guide for clinicians
Flaherty et al. Dissecting delirium: phenotypes, consequences, screening, diagnosis, prevention, treatment, and program implementation
Austin et al. Self‐esteem and symptoms of depression in children with seizures: Relationships with neuropsychological functioning and family variables over time
ESPINO et al. Diagnostic approach to the confused elderly patient
Gerritsen et al. The progression of dementia and cognitive decline in a Dutch 2-year cohort study of people with young-onset dementia
Griffin et al. Developments in understanding early onset Alzheimer's disease
Vöglein et al. Pattern and implications of neurological examination findings in autosomal dominant Alzheimer disease
Nagata et al. Correlation between a reduction in Frontal Assessment Battery scores and delusional thoughts in patients with Alzheimer's disease
Hategan et al. Major or mild neurocognitive disorder due to Alzheimer disease
Mast et al. Alzheimer's disease and dementia
von Gunten et al. Neurocognitive disorders in old age: Alzheimer’s disease, frontotemporal dementia, dementia with Lewy bodies, and prion and infectious diseases
Womack et al. Cognitive Impairment in the Primary Care Clinic
Walter et al. Differentiating Alzheimer disease, Lewy body, and Parkinson dementia using DSM-5
Seixas‐Lima et al. Relationships between neuropsychiatric symptoms and cognitive profiles in Alzheimer's disease and related syndromes
Hustey Dementia in the elderly: avoiding the pitfalls
Hoover et al. After the diagnosis of dementia: Considerations in Disease Management
Crouch Treating dementia
Heirene et al. Draft support and treatment framework for prevention, diagnosis, treatment and support for alcohol-related brain damage [Welsh Government Consultation Document]
JURATOVAC et al. Integrative Management of Disordered Cognition
Ankuda et al. Diagnosis and management of delirium